We also concluded that ER/PR-positive MBCs were more likely to recur compared with ER/PR-negative tumors that showed a lower recurrence rate (43.5% vs. 25.5%, respectively). The gene discussed is ESR1; the disease is maternal uniparental disomy of chromosome 20.